MRg-NIRS Imaging for Breast Cancer
MRg-NIRS Imaging System Breast Cancer Trial
- Age
- 18 – 83
- Sex
- Female
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 20 (estimated)
- Sponsor
- Keith D. Paulsen · Other
This trial is looking for women with breast cancer to see how a new imaging method can help in their treatment. Participants will receive MR-guided near-infrared imaging along with standard care.
You may be able to join if
- I am a female aged 18 or older
- I can provide written consent
- I have a recent diagnosis of breast cancer
- I have an estimated tumor size of 2.0 cm or less
- I had a breast biopsy at least 10 days before the exam
You may not be able to join if
- I have an electronic implant like a pacemaker
- I have a metal implant like an aneurysm clip
- I have claustrophobia
- I have kidney failure
- I am pregnant
- I have breast implants
- I am a prisoner
- I have not healed properly from a breast biopsy
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).
Loading trial locations…